Literature DB >> 6146329

Antihypertensive effect and degree of beta-adrenoceptor blockade after short-term and semi-chronic propranolol therapy.

F H Leenen, P Boer, E J Dorhout Mees.   

Abstract

In patients with normal-renin, mild (n = 6) or moderate (n = 6) hypertension, the antihypertensive effects of propranolol (80 mg/day) for 1 day or for 2 weeks were evaluated in relation to the degree of beta-adrenoceptor blockade induced. A significant and similar fall in systolic blood pressure was observed after 1 day and 2 weeks on propranolol in both groups of patients. In contrast, diastolic blood pressure showed only a minor decrease after 1 day of therapy (-2 +/- 2 and -3 +/- 1 mm Hg) but a significant drop (-7 +/- 3 and -9 +/- 3 mm Hg) after 2 weeks in the mild and moderate hypertension groups, respectively. Plasma propranolol levels and decreases in resting heart rate and PRA were similar after 1 day and 2 weeks of treatment. Isoprenaline dose-response curves for systolic and diastolic blood pressure, heart rate and PRA showed similar parallel shifts after 1 day and 2 weeks of treatment. The effect of graded bicycle exercise on these parameters were also similarly blunted. These results indicate that over time, systolic blood pressure decreases rapidly whereas diastolic blood pressure shows a delayed fall following initiation of low-dose propranolol therapy, despite the same degree of beta-adrenoceptor blockade.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6146329      PMCID: PMC1463430          DOI: 10.1111/j.1365-2125.1984.tb02412.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  20 in total

1.  Plasma concentrations and the time-course of beta blockade due to propranolol.

Authors:  D G McDevitt; D G Shand
Journal:  Clin Pharmacol Ther       Date:  1975-12       Impact factor: 6.875

2.  Alpha and beta adrenergic-induced renin release in man.

Authors:  F H Leenen; D P Redmond; R H McDonald
Journal:  Clin Pharmacol Ther       Date:  1975-07       Impact factor: 6.875

3.  Effects of acute and chronic administration of propranolol on blood pressure and plasma renin activity in hypertensive patients.

Authors:  G S Stokes; M A Weber; I R Thornell; L M Stoker
Journal:  Prog Biochem Pharmacol       Date:  1974

4.  Hemodynamic effects of acute and prolonged beta-adrenergic blockade in essential hypertension.

Authors:  L Hansson; A J Zweifler; S Julius; S N Hunyor
Journal:  Acta Med Scand       Date:  1974 Jul-Aug

5.  Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases.

Authors:  F R Bühler; J H Laragh; L Baer; E D Vaughan; H R Brunner
Journal:  N Engl J Med       Date:  1972-12-14       Impact factor: 91.245

6.  Beta adrenergic blockade in hypertension. Practical and theoretical implications of long-term hemodynamic variations.

Authors:  R C Tarazi; H P Dustan
Journal:  Am J Cardiol       Date:  1972-05       Impact factor: 2.778

7.  Immediate hemodynamic effects of beta-adrenergic blockade with propranolol in normotensive and hypertensive man.

Authors:  M Ulrych; E D Frohlich; H P Dustan; I H Page
Journal:  Circulation       Date:  1968-03       Impact factor: 29.690

8.  Effects of propranolol on development and maintanance of severe renal hypertension in rats.

Authors:  F H Leenen; E W Ackerman
Journal:  Clin Exp Pharmacol Physiol       Date:  1976 Nov-Dec       Impact factor: 2.557

9.  Brain concentration of propranolol in relation to hypotensive effect in the rabbit with observations on brain propranolol levels in man.

Authors:  M G Myers; P J Lewis; J L Reid; C T Dollery
Journal:  J Pharmacol Exp Ther       Date:  1975-02       Impact factor: 4.030

10.  Hypotensive and renin-suppressing activities of propranolol in hypertensive patients.

Authors:  G Leonetti; G Mayer; A Morganti; L Terzoli; A Zanchetti; G Bianchetti; E Di Salle; P L Morselli; C A Chidsey
Journal:  Clin Sci Mol Med Suppl       Date:  1975-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.